Stereospecific binding of the antidepressant rolipram to brain protein structures

https://doi.org/10.1016/0014-2999(86)90210-4Get rights and content

Abstract

The characteristics for the binding of the selective cAMP phosphodiesterase inhibitor and antidepressant agent rolipram to brain and peripheral organs were investigated. (±)-[3H]Rolipram equilibrium binding and Scatchard analysis revealed saturable, reversible, stereospecific, Mg2+-dependent and heat-sensitive binding with an apparent Hill number of 1. Binding was detected both to membrane-bound and soluble sites, with dissociation constants Kd of 1.2 and 2.4 nM, respectively, and binding site concentrations (Bmax) of 19.3 and 23.6 pmol/g rat forebrain. The (−)-enantiomer of rolipram was ca. 20 times more effective than the (+)-enantiomer in displacing (±)-[3H]rolipram from membranes. Rolipram bound to brain tissue of all mammalian species tested including man, while tissue from bird and fish showed less binding. Organs other than brain exhibited only negligible binding. Only specific cAMP phosphodiesterase inhibitors (ICI 63.197, Ro 20-1724) were potent competitors, while rolipram itself was inactive in a variety of receptor binding assays of neuroactive ligands. The kinetics of (−)-[3H]rolipram binding to the particulate fraction revealed a complex association and dissociation behaviour. The nature of the rolipram binding protein(s) is not clear, but the low affinity binding site evident from binding kinetics may represent a rolipram-sensitive phosphodiesterase isoenzyme also common to some peripheral organs, while the high affinity binding site(s) may be related to PDE isoenzymes more confined to the central nervous system.

References (33)

  • H. Wachtel

    Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

    Neuropharmacology

    (1983)
  • M.M. Appleman et al.

    Cyclic nucleotide phosphodiesterases

  • J.P. Bennett et al.

    Neurotransmitter, hormone, or drug receptor binding methods

  • G. Blaschke

    Chromatographische Racemattrennung

    Angew. Chem.

    (1980)
  • E. Bürgisser et al.

    Anomalous equilibrium binding properties of high-affinity racemic radioligands

    Mol. Pharmacol.

    (1981)
  • W.Y. Cheung

    Properties of cyclic nucleotide phosphodiesterase from rat brain

    Biochemistry

    (1967)
  • Cited by (231)

    • Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model

      2017, Neurochemistry International
      Citation Excerpt :

      Hence, inhibition of PDE4 enzyme is a way to augment the cAMP level. Previous studies have been reported that inhibition of PDE4 enzyme induces significant rise in cAMP and augments both the intensity and duration of cAMP signaling (Schneider et al., 1986; Scuvee-Moreau et al., 1987). Previous studies from our lab and elsewhere reported that ETZ belongs to PDE4 inhibitor family and treatment with ETZ restored cAMP level (Chasin et al., 1972; Jindal et al., 2012, 2013; 2015a,b).

    • PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways

      2016, Cellular Signalling
      Citation Excerpt :

      Earlier observations had suggested that the interaction UCR1/UCR2 may be affected by the state of phosphorylation at Ser 54 of PDE4D3, including domain interaction monitored by yeast-two-hybrid [31,32]. When radioactive Rolipram was used to probe binding to PDE4 [33], it was discovered that PDE4s assume two conformations: a high affinity (HARBs) or low affinity (LARBs) rolipram binding conformation [34]. It has been proposed that the high affinity state is determined by the UCR2 capping helix providing an additional interaction point for the inhibitor.

    • Intra-nucleus accumbens shell injections of R(+)- and S(-)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice

      2014, Behavioural Brain Research
      Citation Excerpt :

      One explanation of this result may be differential binding. Other molecules, such as type 1 antiarrhythmic drugs and rolipram exhibit stereospecific binding that is related to molecular rotation of the molecule and differing binding affinity [49,50]. In the case of rolipram, the high affinity binding sites mitigate the antidepressant effects of the drug [51].

    View all citing articles on Scopus
    View full text